Contract VA26215J0012
Actelion Pharmaceuticals Us, Inc. · Department Of Veterans Affairs · October 1, 2014
Actelion Pharmaceuticals Us, Inc. was awarded a federal contract by Department Of Veterans Affairs on October 1, 2014 for $126,000 of work in pharmaceutical preparation manufacturing. Performance is in Woonsocket, RI. This is a task or delivery order issued under parent IDIQ VA797BP0414. The contract has been modified 4 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on January 11, 2016.
Contract details
- PIID
- VA26215J0012
- Parent IDIQ
- VA797BP0414
- Award type
- Bpa Call
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Woonsocket, RI
- First action
- October 1, 2014
- Latest action
- January 11, 2016
Description
MEDICATION
Modification timeline
-
January 11, 2016Mod P00002$-5.5K
-
July 27, 2015Mod P00001$-47.0K
-
December 1, 2014Mod P00001IGF::OT::IGF EXPRESS REPORT FOR FY15 NOVEMBER 2014 (605-C58628)$36.6K
-
November 3, 2014Base awardIGF::OT::IGF EXPRESS REPORT FOR FY15 OCTOBER 2014 (605-C58627)$35.4K
-
October 1, 2014Base award$106.9K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract VA26215J0012?
Contract VA26215J0012 is a federal contract awarded to Actelion Pharmaceuticals Us, Inc. by Department Of Veterans Affairs on October 1, 2014 for $126,000 of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 4 times since the base award.
Who won contract VA26215J0012?
Actelion Pharmaceuticals Us, Inc. won contract VA26215J0012 from Department Of Veterans Affairs.
How much is contract VA26215J0012 worth?
Contract VA26215J0012 has obligated $126,000 to date.